SentinelA new way to search
Sign Up
Cnbc
Cnbc
@cnbc·4.2M subscribers·16.1K videos

Ionis Pharmaceuticals CEO: High-Profile Partners | Mad Money | CNBC

Posted

March 24, 2017

Views

3,084

Likes

19

Comments

2

Engagement

0.68%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

Cnbc Episodes Around March 24, 2017

See what was published immediately before and after this episode.

4:34

Here's Why One Trader Sold All His Stocks | Trading Nation | CNBC

Mar 23, 2017·1.3K views
1:25

President Donald Trump's SEC Pick Jay Clayton Faces Questions On Capitol Hill | CNBC

Mar 23, 2017·1K views
2:35

Cash Diet: How To Socialize And Celebrate On A Tight Budget | Week 6 | CNBC Make It.

Mar 24, 2017·2.4K views
4:46

Why Bullish Strategist Sam Stovall Is Worried | Trading Nation | CNBC

Mar 24, 2017·588 views
3:45

Trading The Buyback Backpedal | Trading Nation | CNBC

Mar 24, 2017·389 views
8:07

Ionis Pharmaceuticals CEO: High-Profile Partners | Mad Money | CNBC

Mar 24, 2017·3.1K views
2:00

White House Issues Ultimatum On Health Care | Squawk Box | CNBC

Mar 24, 2017·347 views
1:50

Markets Expecting a 'No' Vote On Health Care | Squawk Box | CNBC

Mar 24, 2017·372 views
1:56

Retiring At Sea Can Be Cheaper Than Just Staying Home | CNBC

Mar 24, 2017·362.3K views
5:07

OMB Director Mick Mulvaney: President Trump Done Negotiating, Wants Vote Today | Squawk Box | CNBC

Mar 24, 2017·1.5K views
1:16

President Donald Trump Approves Keystone XL Pipeline | CNBC

Mar 24, 2017·2.5K views
View all episodes
YouTubeWebsiteFacebookInstagramApple Podcasts

YouTube Description

as posted by the channel

Goldman recently said Ionis is a company you cannot own, throwing the company's business model into question. Does the claim hold weight? Jim Cramer sat down with CEO Dr. Stanley Crooke to get his take.

» Subscribe to CNBC

» Watch more Mad Money here

» Read more about Ionis Pharmaceuticals here

"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Get More Mad Money!

Read the latest news

Watch full episodes

Follow Mad Money on Twitter

Like Mad Money on Facebook

Follow Cramer on Twitter

Connect with CNBC News Online!

Visit CNBC.com

Find CNBC News on Facebook

Follow CNBC News on Twitter

Follow CNBC News on Google+

Follow CNBC News on Instagram

Ionis Pharmaceuticals CEO: High-Profile Partners | Mad Money | CNBC

Links & Promotions

cnb.cx/SubscribeCNBCbit.ly/WatchMadMoneycnb.cx/2mW90Wpmadmoney.cnbc.combit.ly/MadMoneyEpisodesbit.ly/MadMoneyTwitterbit.ly/LikeMadMoneybit.ly/FollowCramercnbc.comcnb.cx/LikeCNBCcnb.cx/FollowCNBCcnb.cx/PlusCNBCcnb.cx/InstagramCNBC

Guests & Subjects Covered

Ionis Pharmaceuticals CEOJim CramerCEO Dr Stanley CrookeMad MoneyIonis PharmaceuticalsWall Street'sWall StreetAbout CNBC From

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

← All episodes from Cnbc
Ionis Pharmaceuticals CEO: High-Profile Partners | Mad Money | CNBC · CNBC Television · Sentinel